ForumIAS LATEST
- 04 June | MGP Strategy Series | GS Paper 4 (Ethics) with AIR 7 A.R. Rajah Mohaideen Click Here to register for the session →
- 04 June | GS Advance Program begins from 4th June 2026 | First 2 classes open to all Click Here to register for the event →
- 05 June | MGP Strategy Series | GS Paper 3 Strategy Session with AIR 406 Mannat Luthra Click Here to register for the session
- 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
- 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →
- 07 June | Sociology Optional Strategy Session with AIR 10 Ujjwal Priyank Click Here to register →
Mosquito-killing drug offers new tool for fighting malaria
- In a randomized trial in Burkina Faso, the antimalarial effects of ivermectin has shown that it has the potential to reduce malaria episodes. Burkina Faso is a country in western Africa.
- Ivermectin reduces new cases of malaria by making a person’s blood lethal to the mosquitoes who bite them, killing mosquitoes. It therefore reduces the likelihood of infection of others.
- Ivermectin is a drug used to treat parasitic infections such as head lice, river blindness and scabies. Mosquito-killing capabilities of the drug has been known, however, it had not previously been tested for its effects on malaria incidence.
- Malaria is disease caused by Plasmodium parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. According to the World Malaria Report 2018, more than 200 million people were affected by malaria in 2017. Africa has the highest malaria burden.
